According to a new report from Intel Market Research, Global Mantle Cell Lymphoma Therapeutics market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.78 billion by 2034, growing at a steady CAGR of 7.8% during the forecast period (2026–2034). This expansion reflects growing clinical adoption of novel targeted therapies and increasing healthcare investments in rare...